Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Quinidine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 343Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Reeling from a hefty civil and criminal settlement
    Reeling from a hefty civil and criminal settlement

    30 Sep 2019

    // John Carroll ENDPTS

    https://endpts.com/reeling-from-a-hefty-civil-and-criminal-settlement-avanir-stumbles-into-phiii-alzheimers-failure/

    John Carroll ENDPTS
    30 Sep 2019
    Share Share
    Avanir agrees to pay $108M over Neudexta kickbacks probe
    Avanir agrees to pay $108M over Neudexta kickbacks probe

    27 Sep 2019

    // Eric Sagonowsky FIERCE PHARMA

    https://www.fiercepharma.com/pharma/otsuka-s-avanir-agrees-to-pay-108m-over-neudexta-kickbacks-probe

    Eric Sagonowsky FIERCE PHARMA
    27 Sep 2019
    Share Share
    Otsuka’s Alzheimer’s agitation drug hits the mark
    Otsuka’s Alzheimer’s agitation drug hits the mark

    26 Mar 2019

    // Phil Taylor PMLIVE

    http://www.pmlive.com/pharma_news/otsukas_alzheimers_agitation_drug_hits_the_mark_1282509

    Phil Taylor PMLIVE
    26 Mar 2019
    Share Share
    Otsuka expects to pay $120M to wrap the feds' Nuedexta probe
    Otsuka expects to pay $120M to wrap the feds' Nuedexta probe

    15 Feb 2019

    // Eric Sagonowsky FIERCE PHARMA

    https://www.fiercepharma.com/pharma/avanir-nearing-doj-settlement-neudexta-marketing-otsuka-estimates-120m

    Eric Sagonowsky FIERCE PHARMA
    15 Feb 2019
    Share Share
    Medicare alert draws attention to use of laughing drug Nuedexta
    Medicare alert draws attention to use of laughing drug Nuedexta

    04 Jun 2018

    // Eric Palmer FIERCE PHARMA

    https://www.fiercepharma.com/pharma/medicare-wants-insurers-to-monitor-suspicious-prescribing-laughing-drug-nuedexta

    Eric Palmer FIERCE PHARMA
    04 Jun 2018
    Share Share
    Actavis Elizabeth’s Generic Dextromethorphan Hydrobromide;Quinidine Sulfate Receives Approval In US
    Actavis Elizabeth’s Generic Dextromethorphan Hydrobromide;Quinidine Sulfate Receives Approval In US

    12 Oct 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202934

    FDA
    12 Oct 2017
    Share Share